Human Insulin Market by Product (Drug and Drug Delivery Devices) for Type 1 Diabetes, Type 2 Diabetes Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Table of Content Chapter 1. Introduction 1.1. Report Description And Scope 1.2. Research Scope 1.3. Research Methodology 1.3.1. Market Research Process 1.3.2. Market Research Methodology Chapter 2. Executive Summary 2.1. Global Human Insulin Market, 2015 - 2021 (USD Billion) 2.2. Global Human Insulin Market: Snapshot Chapter 3. Human Insulin – Market Dynamics 3.1. Introduction 3.2. Value Chain Analysis 3.3. Market Drivers 3.3.1. Global Human Insulin Market Drivers: Impact Analysis 3.3.2. Rise in Diabetic Patient Population. 3.3.3. Increasing Population Exposure to Key Risk Factors Leading to Diabetes. 3.4. Market Restraints 3.4.1. Global Human Insulin Market Restraints: Impact Analysis 3.4.2. Stringent Regulatory Requirements for Product Approval. 3.5. Opportunities 3.5.1. Emerging Markets 3.6. Porter’s Five Forces Analysis 3.6.1. Bargaining Power Of Suppliers 3.6.2. Bargaining Power Of Buyers 3.6.3. Threat From New Entrants 3.6.4. Threat From New Substitutes 3.6.5. Degree Of Competition 3.7. Market Attractiveness Analysis 3.7.1. Market Attractiveness Analysis, By Type Segment 3.7.2. Market Attractiveness Analysis, By Application Segment 3.7.3. Market Attractiveness Analysis, By Regional Segment Chapter 4. Global Human Insulin Market – Competitive Landscape 4.1. Company Market Share, 2015 (Subject To Data Availability) 4.2. Strategic Development 4.2.1. Acquisitions Mergers 4.2.2. New Type Launch 4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures 4.2.4. Research And Development, Product And Regional Expansion 4.3. Product Portfolio 4.4. Patent Analysis (2011-2016) 4.4.1. Patent Trend 4.4.2. Patent Share By Company 4.4.3. By Region Chapter 5. Global Human Insulin Market – Product Segment Analysis 5.1. Global Human Insulin Market: Product Segment Overview 5.1.1. Global Human Insulin Market Revenue Share, By Product Segment, 2015 And 2021 5.2. Drug 5.2.1. Global Human Insulin Market For Drug , 2015 – 2021 (USD Billion) 5.2.2. Insulin Analogs and Biosimilars 5.2.2.1. Global Human Insulin Market For Insulin Analogs and Biosimilars, 2015 – 2021 (USD Billion) 5.2.3. Human Insulin Biologics 5.2.3.1. Global Human Insulin Market For Human Insulin Biologics, 2015 – 2021 (USD Billion) 5.3. Drug Delivery Devices 5.3.1. Global Human Insulin Market For Drug Delivery Devices, 2015 – 2021 (USD Billion) 5.3.2. Pens 5.3.2.1. Global Human Insulin Market For Pens, 2015 – 2021 (USD Billion) 5.3.3. Pen Needles 5.3.3.1. Global Human Insulin Market For Pen Needles, 2015 – 2021 (USD Billion) 5.3.4. Syringes 5.3.4.1. Global Human Insulin Market For Syringes, 2015 – 2021 (USD Billion) Chapter 6. Global Human Insulin Market – Application Segment Analysis 6.1. Global Human Insulin Market: Application Segment Overview 6.1.1. Global Human Insulin Market Revenue Share, By Application Segment, 2015 And 2021 6.2. Insulin Dependent Diabetes Mellitus (Type 1) 6.2.1. Global Human Insulin Market For Insulin Dependent Diabetes Mellitus, 2015 – 2021 (USD Billion) 6.3. Non-Insulin Dependent Diabetes Mellitus (Type 2) 6.3.1. Global Human Insulin Market For Non-Insulin Dependent Diabetes Mellitus, 2015 – 2021 (USD Billion) Chapter 7. Global Human Insulin Market – Regional Segment Analysis 7.1. Global Human Insulin Market: Regional Overview 7.1.1. Global Human Insulin Market Revenue Share, By Region, 2015 And 2021 7.1.2. Global Human Insulin Market Revenue Share, By Application, 2015 And 2021 7.2. North America 7.2.1. North America Human Insulin Market Revenue, By Product, 2015 – 2021 , (USD Billion) 7.2.2. North America Human Insulin Market Revenue, By Application, 2015 – 2021 , (USD Billion) 7.3. Europe 7.3.1. Europe Human Insulin Market Revenue, By Product, 2015 – 2021 (USD Billion) 7.3.2. North America Human Insulin Market Revenue, By Application, 2015 – 2021 , (USD Billion) 7.4. Asia Pacific 7.4.1. Asia Pacific Human Insulin Market Revenue, By Product, 2015 – 2021 (USD Billion) 7.4.2. North America Human Insulin Market Revenue, By Application, 2015 – 2021 , (USD Billion) 7.5. Latin America 7.5.1. Latin America Human Insulin Market Revenue, By Product, 2015 – 2021 (USD Billion) 7.5.2. North America Human Insulin Market Revenue, By Application, 2015 – 2021 , (USD Billion) 7.6. Middle East And Africa 7.6.1. Middle East And Africa Human Insulin Market Revenue, By Product, 2015 – 2021 (USD Billion) 7.6.2. North America Human Insulin Market Revenue, By Application, 2015 – 2021 , (USD Billion) Chapter 8. Company Profile 8.1. Eli Lilly 8.1.1. Overview 8.1.2. Financials 8.1.3. Type Portfolio 8.1.4. Business Strategy 8.1.5. Recent Developments 8.2. GlaxoSmithCline 8.2.1. Overview 8.2.2. Financials 8.2.3. Type Portfolio 8.2.4. Business Strategy 8.2.5. Recent Developments 8.3. Biocon 8.3.1. Overview 8.3.2. Financials 8.3.3. Type Portfolio 8.3.4. Business Strategy 8.3.5. Recent Developments 8.4. Sanofi Aventis 8.4.1. Overview 8.4.2. Financials 8.4.3. Type Portfolio 8.4.4. Business Strategy 8.4.5. Recent Developments 8.5. Julphar 8.5.1. Overview 8.5.2. Financials 8.5.3. Type Portfolio 8.5.4. Business Strategy 8.5.5. Recent Developments 8.6. Novo Nordisk 8.6.1. Overview 8.6.2. Financials 8.6.3. Type Portfolio 8.6.4. Business Strategy 8.6.5. Recent Developments 8.7. SemBioSys 8.7.1. Overview 8.7.2. Financials 8.7.3. Type Portfolio 8.7.4. Business Strategy 8.7.5. Recent Developments 8.8. Wockhardt 8.8.1. Overview 8.8.2. Financials 8.8.3. Type Portfolio 8.8.4. Business Strategy 8.8.5. Recent Developments Chapter 9. Patents 9.1. U.S. (US Patents) 9.2. Europe (EP documents) 9.3. Japan (Abstracts of Japan) 9.4. Global (WIPO (PCT))

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.